Loss of the phosphatase and tensin homolog (PTEN) phosphatase is the most common mechanism of constitutive activation of PI3K signaling in cancer cells [19], which was documented in 15–30% of primary, and over 60% of androgen-independent metastatic cancers [20,21,22,23,24]. This evidence concerns the gene PTEN and cancer.